repositioned therapeutic (Melior Pharmaceuticals)

N/A

Report date: 2025/01/26 16:51:43
NME

Base Information

Drug Namerepositioned therapeutic (Melior Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMelior Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMelior Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Lung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A